Walgreens - Chicago - Site 162 — Chicago, Illinois

Walgreens - Chicago - Site 162 is a clinical research site located in Chicago, Illinois, United States 60615.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Walgreens - Chicago - Site 162 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Walgreens - Chicago - Site 162?

Walgreens - Chicago - Site 162 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Walgreens - Chicago - Site 162 conducted?

Walgreens - Chicago - Site 162 has 1 clinical trials on record, with 1 currently active. Their work covers Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases.

Is Walgreens - Chicago - Site 162 accredited by Crixeo Health?

Walgreens - Chicago - Site 162 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Walgreens - Chicago - Site 162?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.